Untangling the folding mechanism of the 52-knotted protein UCH-L3

FEBS Journal

Volumn 276, Issue 9, 2009, Pages 2625-2635

  Andersson, Fredrik I ^a   Pina, David G ^a   Mallam, Anna L ^a   Blaser, Georg ^a   Jackson, Sophie E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Folding kinetics; Hyperfluorescent intermediate(s); Knotted proteins; Pbiquitin C terminal hydrolase; Protein folding

Indexed keywords

CHAPERONE; CYSTEINE PROTEINASE; GLOBULAR PROTEIN; POLYPEPTIDE; PROLINE; PROTEASOME; PROTEIN UCH L3; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENZYME KINETICS; FLUORESCENCE; ISOMERIZATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE;

EID: 64149127011     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06990.x     Document Type: Article

References (40)

1. 1 Mallam AL & Jackson SE (2008) Use of protein engineering techniques to elucidate protein folding pathways. Prog Nucleic Acid Res Mol Biol 84, 57–114.
2. 2 Taylor WR (2007) Protein knots and fold complexity: some new twists. Comput Biol Chem 31, 151–162.
3. 3 Virnau P, Mirny LA & Kardar M (2006) Intricate knots in proteins: function and evolution. PLoS Comput Biol 2, 1074–1079.
4. 4 Mallam AL & Jackson SE (2005) Folding studies on a knotted protein. J Mol Biol 346, 1409–1421.
5. 5 Mallam AL & Jackson SE (2006) Probing nature’s knots: the folding pathway of a knotted homodimeric protein. J Mol Biol 359, 1420–1436.
6. 6 Mallam AL & Jackson SE (2007) The dimerization of an [alpha]/[beta]‐knotted protein is essential for structure and function. Structure 15, 111–122.
7. 7 Mallam AL & Jackson SE (2007) A comparison of the folding of two knotted proteins: YbeA and YibK. J Mol Biol 366, 650–665.
8. 8 Mallam AL, Morris ER & Jackson SE (2008) Exploring knotting mechanisms in protein folding. Proc Natl Acad Sci USA 105, 18740–18745.
9. 9 Mallam AL, Onuoha SC, Grossmann JG & Jackson SE (2008) Knotted fusion proteins reveal unexpected possibilities in protein folding. Mol Cell 30, 642–648.
10. 10 Sulkowska JI, Sulkowski P, Szymczak P & Cieplak M (2008) Tightening of knots in proteins. Phys Rev Lett 100, doi:DOI: 10.1103/PhysRevLett.100.058106.
11. 11 Wallin S, Zeldovich KB & Shakhnovich EI (2007) The folding mechanics of a knotted protein. J Mol Biol 368, 884–893.
12. 12 Mallam AL (2009) How does a knotted protein fold? FEBS J 276, 365–375.
13. 13 Love KR, Catic A, Schlieker C & Ploegh HL (2007) Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol 3, 697–705.
14. 14 Misaghi S, Galardy PJ, Meester WJN, Ovaa H, Ploegh HL & Gaudet R (2005) Structure of the ubiquitin hydrolase UCH‐L3 complexed with a suicide substrate. J Biol Chem 280, 1512–1520.
15. 15 Liu YC, Fallon L, Lashuel HA, Liu ZH & Lansbury PT (2002) The UCH‐L1 gene encodes two opposing enzymatic activities that affect alpha‐synuclein degradation and Parkinson’s disease susceptibility. Cell 111, 209–218.
16. 16 Larsen CN, Krantz BA & Wilkinson KD (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C‐terminal hydrolases. Biochemistry 37, 3358–3368.
17. 17 Larsen CN, Price JS & Wilkinson KD (1996) Substrate binding and catalysis by ubiquitin C‐terminal hydrolases: identification of two active site residues. Biochemistry 35, 6735–6744.
18. 18 Johnston SC, Riddle SM, Cohen RE & Hill CP (1999) Structural basis for the specificity of ubiquitin C‐terminal hydrolases. EMBO J 18, 3877–3887.
19. 19 Pickart CM & Rose IA (1985) Ubiqutin carboxyl‐terminal hydrolase acts on ubiqutin carboxyl‐terminal amides. J Biol Chem 260, 7903–7910.
20. 20 Walters BJ, Campbell SL, Chen PC, Taylor AP, Schroeder DG, Dobrunz LE, Artavanis‐Tsakonas K, Ploegh HL, Wilson JA, Cox GA et al. (2008) Differential effects of Usp14 and Uch‐L1 on the ubiquitin proteasome system and synaptic activity. Mol Cell Neurosci 39, 539–548.
21. 21 Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, Taguchi T, Tamaki Y & Noguchi S (2006) High expression of ubiquitin carboxy‐terminal hydrolase‐L1 and ‐L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci 97, 523–529.
22. 22 Carmine Belin A, Westerlund M, Bergman O, Nissbrandt H, Lind C, Sydow O & Galter D (2007) S18Y in ubiquitin carboxy‐terminal hydrolase L1 (UCH‐L1) associated with decreased risk of Parkinson’s disease in Sweden. Parkinsonism Relat Disord 13, 295–298.
23. 23 Gong B, Cao ZX, Zheng P, Vitolo OV, Liu SM, Staniszewski A, Moolman D, Zhang H, Shelanski M & Arancio O (2006) Ubiquitin hydrolase Uch‐L1 rescues beta‐amyloid‐induced decreases in synaptic function and contextual memory. Cell 126, 775–788.
24. 24 Setsuie R & Wada K (2007) The functions of UCH‐L1 and its relation to neurodegenerative diseases. Neurochem Int 51, 105–111.
25. 25 Huang L & Makarov DE (2008) Translocation of a knotted polypeptide through a pore. J Chem Phys 129, doi:DOI: 10.1063/1.2968554.
26. 26 Jackson SE & Fersht AR (1991) Folding of chymotrypsin inhibitor‐2.1. Evidence for a 2‐state transition. Biochemistry 30, 10428–10435.
27. 27 Wallace LA & Matthews CR (2002) Sequential vs. parallel protein‐folding mechanisms: experimental tests for complex folding reactions. Biophys Chem 101, 113–131.
28. 28 Grathwohl C & Wuthrich K (1981) NMR‐studies of the rates of proline cis–trans isomerization in oligopeptides. Biopolymers 20, 2623–2633.
29. 29 Ruan K & Balny C (2002) High pressure static fluorescence to study macromolecular structure–function. Biochim Biophys Acta Protein Struct Mol Enzymol 1595, 94–102.
30. 30 Ervin J, Larios E, Osvath S, Schulten K & Gruebele M (2002) What causes hyperfluorescence: folding intermediates or conformationally flexible native states? Biophys J 83, 473–483.
31. 31 Ayed A & Duckworth H (1999) A stable intermediate in the equilibrium unfolding of Escherichia coli citrate synthase. Protein Sci 8, 1116–1126.
32. 32 Jemth P, Gianni S, Day R, Li B, Johnson CM, Daggett V & Fersht AR (2004) Demonstration of a low‐energy on‐pathway intermediate in a fast‐folding protein by kinetics, protein engineering, and simulation. Proc Natl Acad Sci USA 101, 6450–6455.
33. 33 Pradeep L, Shin H‐C & Scheraga HA (2006) Correlation of folding kinetics with the number and isomerization states of prolines in three homologous proteins of the RNase family. FEBS Lett 580, 5029–5032.
34. 34 Capaldi AP, Shastry MCR, Kleanthous C, Roder H & Radford SE (2001) Ultrarapid mixing experiments reveal that Im7 folds via an on‐pathway intermediate. Nat Struct Mol Biol 8, 68–72.
35. 35 Eifler N, Vetsch M, Gregorini M, Ringler P, Chami M, Philippsen A, Fritz A, Muller SA, Glockshuber R, Engel A et al. (2006) Cytotoxin ClyA from Escherichia coli assembles to a 13‐meric pore independent of its redox‐state. EMBO J 25, 2652–2661.
36. 36 Friel CT, Beddard GS & Radford SE (2004) Switching two‐state to three‐state kinetics in the helical protein Im9 via the optimisation of stabilising non‐native interactions by design. J Mol Biol 342, 261–273.
37. 37 Otto MR, Lillo MP & Beechem JM (1994) Resolution of multiphasic reactions by the combination of fluorescence total‐intensity and anistropy stopped‐flow kinetic‐experiments. Biophys J 67, 2511–2521.
38. 38 Chen Y & Barkley MD (1998) Toward understanding tryptophan fluorescence in proteins. Biochemistry 37, 9976–9982.
39. 39 Roder H, Maki K & Cheng H (2006) Early events in protein folding explored by rapid mixing methods. Chem Rev 106, 1836–1861.
40. 40 Royer CA, Mann CJ & Matthews CR (1993) Resolution of the fluorescence equilibrium unfolding profile of Trp apo‐repressor using single tryptophan mutants. Protein Sci 2, 1844–1852.